Figure 5.
V79 CBPI and frequency of micronuclei (percentage of binucleated cells containing micronuclei (%Mn/BN)) determined by the in vitro CBMN assay following 1 cell cycle exposure to Au5nm, Au30nm, SiO2, BaSO4, and CeO2 ENPs (A, B, C, D, and E, respectively). Positive controls used were ethyl methanesulfonate (EMS) at 600 µg/ml and tungsten carbide-cobalt (WC/Co) at 30 and 100 µg/ml. These data were generated in laboratory 2, where the results were considered statistically significant (*) when P ≤ .05 (n = 2).

V79 CBPI and frequency of micronuclei (percentage of binucleated cells containing micronuclei (%Mn/BN)) determined by the in vitro CBMN assay following 1 cell cycle exposure to Au5nm, Au30nm, SiO2, BaSO4, and CeO2 ENPs (A, B, C, D, and E, respectively). Positive controls used were ethyl methanesulfonate (EMS) at 600 µg/ml and tungsten carbide-cobalt (WC/Co) at 30 and 100 µg/ml. These data were generated in laboratory 2, where the results were considered statistically significant (*) when P ≤ .05 (n = 2).

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close